Report
US judge rejects Novo Nordisk bid to block Eli Lilly weight-loss drug ads
Reuters reports Novo called the ads misleading, but the judge found its claim of irreparable harm inadequate for an injunction.
TLDR
Reuters reports that a US judge rejected Novo Nordisk’s request to temporarily halt Eli Lilly’s weight-loss drug ads while its lawsuit proceeds. Novo says the ads compare higher doses of Lilly’s Zepbound and Mounjaro with lower doses of Novo’s Wegovy and Ozempic to claim Lilly’s drugs are superior. Lilly denies wrongdoing.
Combined views
80.8K
3 Sources, first seen ago